Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Ramtin Lichtenberger
Observed names:
Lichtenberger, Ramtin,
R. Lichtenberger
Institutions:
University of Zurich,
University Hospital Zurich
Observed institutions:
German Cancer Research Center,
University of Zurich,
Heidelberg University,
University Hospital Zurich,
University Medical Centre Mannheim
ORCID:
0000-0002-7682-0238
Observed ORCID:
0000-0002-7682-0238
OpenAlex ID:
A5091371760
Myeloid Cells and Related Chronic Inflammatory Factors as Novel Predictive Markers in Melanoma Treatment with Ipilimumab
2015
·
Christoffer Gebhardt
, Alexandra Sevko
, et al.
·
Clinical Cancer Research
·
390
Tumor microenvironment-derived S100A8/A9 is a novel prognostic biomarker for advanced melanoma patients and during immunotherapy with anti-PD-1 antibodies
2019
·
Nikolaus B. Wagner
, Benjamin Weide
, et al.
·
Journal for ImmunoTherapy of Cancer
·
109
PDF
Genetic architecture of acne vulgaris
2017
·
R. Lichtenberger
, M.A. Simpson
, et al.
·
Journal of the European Academy of Dermatology and Venereology
·
68
Biomarker value and pitfalls of serum S100B in the follow‐up of high‐risk melanoma patients
2016
·
Christoffer Gebhardt
, Ramtin Lichtenberger
, et al.
·
JDDG Journal der Deutschen Dermatologischen Gesellschaft
·
53
Diminished levels of the soluble form of RAGE are related to poor survival in malignant melanoma
2015
·
Nikolaus B. Wagner
, Benjamin Weide
, et al.
·
International Journal of Cancer
·
42
PDF
Sex Disparities of Health-related Quality of Life in Moderate to Severe Psoriasis: A Real-world Analysis from the Swiss Psoriasis Registry (SDNTT)
2025
·
Ramtin Lichtenberger
, Lara Valeska Maul
, et al.
·
Acta Dermato Venereologica
·
3
PDF
RAGE ligand S100A8/A9 as a novel prognostic biomarker for high-risk melanoma patients.
2014
·
Christoffer Gebhardt
, Nikolaus B. Wagner
, et al.
·
Journal of Clinical Oncology
·
2
Auto-inflammation and the Skin
2018
·
Ramtin Lichtenberger
, Emmanuel Contassot
, et al.
·
Springer eBooks
·
1
The Swiss National Psoriasis Registry (SDNTT): Impact of Psoriasis Therapies on Quality of Life: An Analysis of Sex Differences
2023
·
Ramtin Lichtenberger
, Lara Valeska
, et al.
Data from Myeloid Cells and Related Chronic Inflammatory Factors as Novel Predictive Markers in Melanoma Treatment with Ipilimumab
2023
·
Christoffer Gebhardt
, Alexandra Sevko
, et al.
Supplementary Figure Legends from Myeloid Cells and Related Chronic Inflammatory Factors as Novel Predictive Markers in Melanoma Treatment with Ipilimumab
2023
·
Christoffer Gebhardt
, Alexandra Sevko
, et al.
Supplementary Table 1. from Myeloid Cells and Related Chronic Inflammatory Factors as Novel Predictive Markers in Melanoma Treatment with Ipilimumab
2023
·
Christoffer Gebhardt
, Alexandra Sevko
, et al.
Supplementary Fig. 2 from Myeloid Cells and Related Chronic Inflammatory Factors as Novel Predictive Markers in Melanoma Treatment with Ipilimumab
2023
·
Christoffer Gebhardt
, Alexandra Sevko
, et al.
Supplementary Fig. 1 from Myeloid Cells and Related Chronic Inflammatory Factors as Novel Predictive Markers in Melanoma Treatment with Ipilimumab
2023
·
Christoffer Gebhardt
, Alexandra Sevko
, et al.
Novel Predictive Biomarkers in Melanoma Treatment with Ipilimumab
2015
·
Christoffer Gebhardt
, Alexandra Sevko
, et al.
Show more works
View as search
Works count:
18
Citation count:
667
H-index:
5
I10-index:
5
Year
Topic
Type